SHR-4610 / Jiangsu Hengrui Pharma - LARVOL DELTA

SHR-8068-207-RCC: Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom (clinicaltrials.gov) - P1/2 | N=92 | Recruiting | Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | N=139 ➔ 92

Enrollment change • Clear Cell Renal Cell Carcinoma • Genito-urinary Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor

SHR-4610-101: A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1/2 | N=258 | Recruiting | Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Solid Tumor